Large vessel cardioembolic stroke and embolic stroke of undetermined source share a common profile of matrix metalloproteinase‐9 level and susceptibility vessel sign length
Hanan Alhazmi(Hospices Civils de Lyon), Laura Mechtouff(Hospices Civils de Lyon), Claire Crola Da Silva(Lyon 1 Université), Thomas Bochaton(Hospices Civils de Lyon), Michel Ovize(Université Claude Bernard Lyon 1), Omer Eker(Inserm), Alexandre Bani‐Sadr(Lyon 1 Université), Camille Amaz(Université Claude Bernard Lyon 1), Norbert Nighoghossian(Université Claude Bernard Lyon 1), Tae‐Hee Cho(Lyon 1 Université), Yves Berthezène(Université Claude Bernard Lyon 1), Alexandre Paccalet(Harvard University), Marielle Buisson(Inserm), Roxana Améli(Lyon 1 Université)
Cited by 11
Related Papers
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
How Does Amniotic Membrane Work?
|The Ocular Surface|2004|312
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial
|The Lancet|2022|292
Remote Ischemic Perconditioning as an Adjunct Therapy to Thrombolysis in Patients With Acute Ischemic Stroke
|Stroke|2013|282
Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size
|New England Journal of Medicine|2024|276